ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 275

Environmental Risk Factors and Development of Juvenile Idiopathic Arthritis

Susan Shenoi1, Kathryn B Whitlock2 and Carol A Wallace3, 1Pediatric Rheumatology, Seattle Childrens Hospital, seattle, WA, 2Core for Biomedical Statistics, Seattle Children's Hosptial, Seattle, WA, 3Pediatric Rheumatology, Seattle Children's Hospital/Univ of Washington, Seattle, WA

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Environmental factors and juvenile arthritis

  • Tweet
  • Email
  • Print
Session Information

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects: Juvenile Idiopathic Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose

Juvenile Idiopathic Arthritis (JIA) is a heterogenous group of disorders that is characterized by chronic arthritis in children without known etiology. Environmental factors that act as triggers in a genetically susceptible host are one of the current postulated etiologies of JIA. Although research that focusses on environmental risk factors in JIA is scant, to date there has been some data to suggest a role of infections, exposure to smoking and lack of breastfeeding. This case control study examines the association of selected environmental risk factors in children with JIA.

Methods

JIA cases were identified at outpatient rheumatology clinic visits over 18 months (2012 to 2013) at a major Children’s facility. Enrolled JIA cases were asked to identify three control playmates of similar age and gender without JIA. Both cases and controls completed a one time questionnaire on environmental risk factors in reference to critical time period (at JIA case symptom onset). Controls who responded were frequency-matched to cases by age and gender. Logistic regression adjusted for age and gender was used to determine associations with JIA, and odds ratios are reported with 95% confidence intervals.

Results

223 JIA cases and 86 controls submitted data that was analyzed. Baseline demographic characteristics were similar between cases and controls. Approximately 5% of mothers smoked during pregnancy among cases and controls with OR 0.8 (95% CI: 0.3 -2.4; p value 0.7). Maternal smoking at JIA onset had OR 1 (95% CI: 0.5 -2.3). The odds of JIA for other selected environmental risk factors were as follows: breastfeeding in first year of life: 1.1 (95% CI: 0.6 -2.1), hospitalization with infection in first year of life: 1.7 (95% CI: 0.5 – 5), daycare attendance <6 years of age 1.3 (95% CI: 0.8 – 2.1), household pets 1.2 (95% CI: 0.7 - 2), urban residence 0.7 (95% CI: 0.4 -1.1), stressors in family (death, divorce, move, new school, unemployment) 1 (95% CI: 0.6 -1.7). Limitations of the study include selection bias as cases were identified though outpatient rheumatology visits and overmatching that was accounted for in the analysis.

Conclusion

There was no association between maternal smoking during pregnancy or subsequent maternal smoking at JIA symptom onset, infections in first year of life, daycare attendance, household pets, urban residence or family stressors and development of JIA in this case control study.


Disclosure:

S. Shenoi,
None;

K. B. Whitlock,
None;

C. A. Wallace,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/environmental-risk-factors-and-development-of-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology